Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Tanibirumab |
Trade Name | |
Synonyms | TTAC-0001|Olinvacimab |
Drug Descriptions |
Tanibirumab (TTAC-0001) is a monoclonal antibody directed against KDR (VEGFR2), which may inhibit tumor angiogenesis (PMID: 21910042, PMID: 29563774). |
DrugClasses | VEGFR2 Antibody 4 |
CAS Registry Number | 2095504-49-5 |
NCIT ID | C102877 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Fluorouracil + Tanibirumab | Fluorouracil Tanibirumab | 0 | 0 |
Pembrolizumab + Tanibirumab | Pembrolizumab Tanibirumab | 0 | 1 |
Tanibirumab | Tanibirumab | 0 | 1 |